These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 24927818)
21. Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies. Luk C; Giovannoni G; Williams DR; Lees AJ; de Silva R J Neurosci Methods; 2009 May; 180(1):34-42. PubMed ID: 19427527 [TBL] [Abstract][Full Text] [Related]
22. The Role of Tau Proteoforms in Health and Disease. Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762 [TBL] [Abstract][Full Text] [Related]
23. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344 [TBL] [Abstract][Full Text] [Related]
24. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576 [TBL] [Abstract][Full Text] [Related]
25. Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases. Nogami A; Yamazaki M; Saito Y; Hatsuta H; Sakiyama Y; Takao M; Kimura K; Murayama S J Nippon Med Sch; 2015; 82(6):266-73. PubMed ID: 26823029 [TBL] [Abstract][Full Text] [Related]
26. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Liu WK; Le TV; Adamson J; Baker M; Cookson N; Hardy J; Hutton M; Yen SH; Dickson DW Ann Neurol; 2001 Oct; 50(4):494-502. PubMed ID: 11601500 [TBL] [Abstract][Full Text] [Related]
27. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease. Stancu IC; Ferraiolo M; Terwel D; Dewachter I Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036 [TBL] [Abstract][Full Text] [Related]
28. Tau-positive fine granules in the cerebral white matter: a novel finding among the tauopathies exclusive to parkinsonism-dementia complex of Guam. Yamazaki M; Hasegawa M; Mori O; Murayama S; Tsuchiya K; Ikeda K; Chen KM; Katayama Y; Oyanagi K J Neuropathol Exp Neurol; 2005 Oct; 64(10):839-46. PubMed ID: 16215455 [TBL] [Abstract][Full Text] [Related]
30. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD. Bowles KR; Pugh DA; Oja LM; Jadow BM; Farrell K; Whitney K; Sharma A; Cherry JD; Raj T; Pereira AC; Crary JF; Goate AM Acta Neuropathol; 2022 Feb; 143(2):225-243. PubMed ID: 34874463 [TBL] [Abstract][Full Text] [Related]
31. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Togo T; Dickson DW Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627 [TBL] [Abstract][Full Text] [Related]
32. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792 [TBL] [Abstract][Full Text] [Related]
33. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Mori H; Nishimura M; Namba Y; Oda M Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491 [TBL] [Abstract][Full Text] [Related]
34. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods. Uchihara T; Tsuchiya K; Nakamura A; Akiyama H Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055 [TBL] [Abstract][Full Text] [Related]
35. Tau and saitohin gene expression pattern in progressive supranuclear palsy. Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Chambers CB; Lee JM; Troncoso JC; Reich S; Muma NA Ann Neurol; 1999 Sep; 46(3):325-32. PubMed ID: 10482263 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765 [TBL] [Abstract][Full Text] [Related]
38. A Machine Learning-Based Approach to Discrimination of Tauopathies Using [ Endo H; Tagai K; Ono M; Ikoma Y; Oyama A; Matsuoka K; Kokubo N; Hirata K; Sano Y; Oya M; Matsumoto H; Kurose S; Seki C; Shimizu H; Kakita A; Takahata K; Shinotoh H; Shimada H; Tokuda T; Kawamura K; Zhang MR; Oishi K; Mori S; Takado Y; Higuchi M Mov Disord; 2022 Nov; 37(11):2236-2246. PubMed ID: 36054492 [TBL] [Abstract][Full Text] [Related]